What is the MMA test and what does the result mean?

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

MMA is the tie-breaker test. B12 powers the enzyme that clears methylmalonic acid, so when usable B12 runs short inside cells, MMA rises. UK guidance (NICE NG239) uses MMA as the second-line check when total B12 sits in the indeterminate 180 to 350 ng/L zone. There is no single reference range, and labs commonly place the adult upper cutoff somewhere around 0.27 to 0.45 micromoles per litre, so read the result against the issuing lab's own range. Kidney function matters, because MMA is cleared by the kidneys and a raised result can reflect reduced clearance rather than low B12. Any B12 supplement lowers MMA, so test before supplementing.

Free B12 and folate result interpreter

Enter what you have. Your B12 alone works; folate and the confirmatory markers sharpen the reading. Nothing you enter leaves this device. Nothing is saved. No AI is used, only published UK guideline thresholds.

Total B12
Active B12 (pmol/L)
Folate (nmol/L)
Homocysteine (umol/L)
MCV (fL)

I was taking a B12 supplement or had an injection before this test

This tool gives educational interpretation of published evidence. It is not personal dosing advice and it does not diagnose. It knows nothing about your history, symptoms or other results. Interpreting your results over time, alongside everything else about you, is what Nutri365 does.

How it works

B12 is the cofactor for methylmalonyl-CoA mutase, the enzyme that converts methylmalonyl-CoA into succinyl-CoA. When cells lack usable B12 the conversion stalls, methylmalonyl-CoA is hydrolysed to free methylmalonic acid, and MMA rises in the blood. That is why MMA is called a functional marker. Serum B12 counts what is circulating; MMA reports whether the B12-dependent machinery inside cells is actually running. MMA is also more specific to B12 than homocysteine, which rises in folate and B6 deficiency as well.

Effective dose

MMA is a test, not a supplement, so the dose question here is about what testing decisions follow. A raised MMA with low or borderline B12 supports genuine deficiency and routes to the GP-led pathway, where the cause determines whether oral B12 or injections apply. A raised MMA with normal B12 does not have a supplement answer, because the likelier explanations are renal clearance or other metabolism, and that result belongs with a GP.

Forms compared

MMA is usually measured in serum or plasma. A urinary MMA-to-creatinine ratio exists and is less affected by kidney function, but serum MMA is what UK labs typically run in the B12 workup.

Timing

Test before supplementing. Any B12 supplement restores mutase activity and lowers MMA within weeks, which is exactly what you want after a confirmed deficiency and exactly what you do not want before one, because it can normalise the result while the underlying cause goes unexamined. If a B12 workup is planned, hold off starting B12 and mention anything already being taken.

Safety profile

The test itself is a standard blood draw. The interpretive risk sits in over-reading a raised MMA as proof of B12 deficiency when kidney function is reduced, and in under-reading a normal-B12-raised-MMA pattern that deserves a renal look. Both readings belong with a GP rather than a supplement decision.

Special populations

MMA runs higher with age even without deficiency. In a general-population study of adults aged 60 to 75, the median MMA was around 170 nmol/L, and both lower B12 and lower kidney function independently pushed MMA up. Older adults, and anyone with known kidney impairment, need their MMA read against that context rather than a young-adult expectation.

Interactions

B12 supplements in any form lower MMA. Reduced kidney function raises it. Metformin and proton pump inhibitors, which lower B12 absorption over long-term use, can indirectly raise MMA by depleting B12, which is one reason long-term users of either drug feature in UK testing guidance.

Guideline positions

NICE NG239 (2024) positions MMA as the second-line marker when total serum B12 falls in the 180 to 350 ng/L indeterminate zone, alongside clinical judgement, with active B12 below 25 pmol/L reading as deficient. No UK-wide MMA reference range is set. Laboratory ranges vary, with common adult upper cutoffs in the region of 0.27 to 0.45 micromoles per litre, and the issuing lab's range is the one that applies.

Practical framework

The MMA question usually starts one step earlier, with a total B12 result between 180 and 350 ng/L. If that is where you are, the next step is MMA or active B12 through the GP, not a supplement. Read the MMA result against the lab's own range, check whether a recent kidney function result (eGFR) sits alongside it, and read the pair together. The Nutri365 Blood Result Interpreter reads a B12 panel against the NG239 thresholds directly in the browser, with nothing stored. A raised MMA, whatever the B12 result, is a GP conversation.

Common misconceptions

A raised MMA does not automatically mean B12 deficiency, because reduced renal clearance raises MMA with no B12 problem at all. A normal MMA does not always end the story either, since a small number of people with classic deficiency features respond to B12 despite normal markers, which is why UK practice pairs the numbers with the clinical picture. And there is no universal cutoff. Quoting a single MMA threshold without naming the lab range behind it is a sign the source is oversimplifying.

Sources

National Institute for Health and Care Excellence (NICE, UK government) 2024. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). National Institute for Health and Care Excellence (NICE).
Riphagen IJ, Minovic I, Groothof D, Post A, Eggersdorfer ML, Kootstra-Ros JE, de Borst MH, Navis G, Muskiet FAJ, Kema IP, Heiner-Fokkema MR, Bakker SJL 2020. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality in the general population: results from the prospective Lifelines-MINUTHE study. BMC Medicine 18(1):380, DOI 10.1186/s12916-020-01853-x, PMID 33298054.
Pernicious Anaemia Society 2018. Methylmalonic Acid (MMA) and Vitamin B12 Deficiency. Pernicious Anaemia Society (UK charity).

Back to B Vitamins overview